| Drug class |
Angiotensin‑converting‑enzyme (ACE) inhibitor |
Fixed‑dose combo: ACE inhibitor + thiazide diuretic |
| Typical indications |
• Primary hypertension • Post‑myocardial‑infarction heart failure • Chronic kidney disease (CKD) with proteinuria (in some countries) |
• Primary hypertension (especially stage 1 or when a single drug isn’t enough) • Hypertension in patients who also need a diuretic (e.g., salt‑retaining conditions, edema) • Certain heart‑failure patients who benefit from dual therapy |
| Mechanism of action |
Blocks conversion of angiotensin I → angiotensin II → ↓ vasoconstriction, ↓ aldosterone → ↓ blood pressure |
Same ACE inhibition plus diuretic effect: HCTZ inhibits Na⁺/Cl⁻ reabsorption in the distal tubule → ↑ urine output → ↓ plasma volume, ↓ blood pressure |
| Typical starting doses |
• 5 mg once daily (often titrated up) • Max 40 mg/d |
• 10 mg lisinopril + 12.5 mg HCTZ (often titrated up) • Max 20 mg lisinopril + 25 mg HCTZ or 40 mg + 50 mg (depends on label) |
| Dosing flexibility |
Very flexible – any dose from 2.5 mg to 40 mg can be used individually |
Fixed ratios – you can’t give just a lower dose of lisinopril or HCTZ without changing the other component |
| Key side‑effects (ACE‑I) |
• Persistent dry cough • Hyperkalemia (especially with renal disease or potassium‑sparing diuretics) • Angioedema (rare) • Hypotension (postural) |
Same ACE‑I side‑effects plus diuretic‑related issues: • Hypokalemia • Dehydration, dizziness • Hyperglycemia & hyperuricemia (especially in diabetics, gout patients) |
| Why combine them? |
Lisinopril alone often suffices, but some patients need a second agent to hit BP targets. |
HCTZ lowers blood pressure through volume reduction; combining it with lisinopril provides a synergistic effect, often improving BP control with a single pill—great for adherence. |
| Special considerations |
• Avoid in pregnancy (causes fetal kidney damage) • Avoid if severe renal impairment or hyperkalemia • Monitor blood pressure and potassium |
• Same ACE‑I restrictions • Avoid in pregnancy (both components are contraindicated) • Avoid if severe CKD, hyperkalemia, or if you’re already on a diuretic (over‑diuresis risk) • Be mindful of the fixed dose; you can’t titrate the diuretic independently |
| Use in heart‑failure |
Lisinopril reduces mortality and morbidity in systolic heart‑failure. |
The combination can help control BP and reduce fluid overload, but it hasn’t been shown to improve survival in heart‑failure beyond what lisinopril alone does. |
| Cost / access |
Usually cheaper when bought separately (generic). |
Combination product (e.g., Co‑Diovan in the U.S.) can be slightly more expensive, but often covered by insurance; may be cheaper than buying two separate drugs. |
| Patient adherence |
May need two separate pills if titrating dose, which can lower adherence. |
One pill for two agents → better adherence for many patients. |
| Renal function |
Requires dose adjustment in CKD; monitor GFR and potassium. |
Same caution; plus watch for diuretic‑induced dehydration or worsening renal function. |